Hemoperfusion

Hemoperfusion is an extracorporeal therapy that involves circulating a patient's blood through a purification filter, also known as an adsorption column. This filter removes specific targets, such as toxins or drug molecules, from the bloodstream.

Hemoperfusion is an extracorporeal blood purification technique that involves circulating a patient's blood through an adsorption column, where targeted toxins and harmful substances are selectively removed from the bloodstream. A dual-lumen dialysis catheter is placed in a central vein, allowing blood to be withdrawn, purified through the column, and then returned to the patient. The adsorption process occurs as blood passes through the column, with toxins adhering to the adsorbent material based on their molecular properties. This method provides a rapid and efficient means of toxin removal, often leading to improved patient outcomes in cases of severe intoxication or poisoning. Hemoperfusion is selective in what it removes from the blood, making it a valuable tool for treating various conditions where traditional therapies may be ineffective. When performed by trained veterinary professionals and closely monitored, hemoperfusion is generally considered safe and can significantly contribute to the patient's recovery.

Preparation:

A traditional dialysis catheter is placed in a central vein, typically the right jugular vein. This catheter has an inlet and return line, allowing for the continuous withdrawal and return of blood.

Installation of AimaLojic Blood Purification Filter:

The AimaLojic Blood Purification Filter, also referred to as a column, is placed into the ReVive HP pump.

Initiation of Treatment:

Once the catheter is in place and the AimaLojic Blood Purification Filter is installed in the ReVive HP pump, the treatment process begins. The ReVive HP pump is turned on, initiating the circulation of the patient's blood through the purification filter/column.

Treatment Duration:

Over the next 30 to 90 minutes, the patient's blood is continuously circulated through the purification filter/column. During this time, the filter rapidly removes toxins or targeted substances from the bloodstream.

Return of Filtered Blood:

As the blood passes through the AimaLojic Blood Purification Filter, toxins are adsorbed and removed. The filtered, purified blood is then returned back into the patient's bloodstream through the dialysis catheter.

The AimaLojic device is designed to treat a variety of severe intoxications, including overdoses of substances like ibuprofen, NSAIDs, acetaminophen, phenobarbital, meloxicam, methotrexate, vincristine, and 5-HTP. It can also be used for other applications such as inflammatory and autoimmune diseases.

Expedited Treatment and Improved Success Rates:

This technology has the potential to save lives in as little as 90 minutes, compared to the current standard of care which may require patients to remain in the ICU for 3 - 5 days.

Reduced Morbidity and Mortality:

Patients who receive hemoperfusion treatment with AimaLojic have a reduced risk of lasting organ dysfunction and complications. This results in improved quality of life and potentially a longer lifespan for treated animals.

Efficient Treatment and Discharge:

AimaLojic hemoperfusion technology enables cases that would traditionally require extended hospital stays to be treated and discharged the same day or the next day. This streamlines the workflow of the clinic, allowing for more efficient use of resources and staff time.

Referral Magnet:

Clinics that offer AimaLojic hemoperfusion become a referral magnet for local veterinary clinics. This can attract more cases and referrals, enhancing the clinic's reputation as a provider of advanced and life-saving treatments.

Critical Role in Treatment:

Veterinary technicians play a crucial role in the hemoperfusion process. They are empowered to set up the machine, monitor the progress of treatment, and ensure the well-being of the patient. Investing in skilled technicians, as recommended by the Hemodialysis Academy, enhances the efficiency and effectiveness of the treatment process.

Improved Profitability:

Traditional therapies for intoxications often lead to low profitability due to extended hospital stays and resource-intensive care. Treating patients with AimaLojic hemoperfusion technology frees up workflow, allowing clinics to see more cases and potentially charge more for this novel and advanced therapy.

Yes, when used appropriately by trained veterinary professionals, AimaLojic hemoperfusion technology is considered safe for use in treating animals.